MARKET WIRE NEWS

Pacific Biosciences of California, Inc. (PACB) Q2 2025 Earnings Call Transcript

Source: SeekingAlpha

2025-08-08 20:18:44 ET

Pacific Biosciences of California, Inc. (PACB)

Q2 2025 Earnings Conference Call

August 07, 2025, 5:00 PM ET

Company Participants

Christian O. Henry - President, CEO & Director

James R. Gibson - Chief Financial Officer

Todd Friedman - Corporate Participant

Conference Call Participants

David Michael Westenberg - Piper Sandler & Co., Research Division

Douglas Anthony Schenkel - Wolfe Research, LLC

Jack Meehan - Nephron Research LLC

Kyle Alexander Mikson - Canaccord Genuity Corp., Research Division

Mason Owen Carrico - Stephens Inc., Research Division

Subhalaxmi T. Nambi - Guggenheim Securities, LLC, Research Division

Thomas Patrick Stevens - TD Cowen, Research Division

Presentation

Operator

Good afternoon, and welcome to the PacBio Second Quarter 2025 Earnings Conference Call. [Operator Instructions] Please note, this event is being recorded.

I would now like to turn the conference over to Todd Friedman, Director of Investor Relations. Please go ahead....

Read the full article on Seeking Alpha

For further details see:

Pacific Biosciences of California, Inc. (PACB) Q2 2025 Earnings Call Transcript
Pacific Biosciences of California Inc.

NASDAQ: PACB

PACB Trading

4.72% G/L:

$1.33 Last:

3,202,013 Volume:

$1.30 Open:

mwn-ir Ad 300

PACB Latest News

February 12, 2026 07:03:04 pm
PacBio (PACB) Q4 2025 Earnings Call Transcript

PACB Stock Data

$549,471,524
294,359,745
0.64%
78
N/A
Biotechnology & Life Sciences
Healthcare
US
Menlo Park

Subscribe to Our Newsletter

Link Market Wire News to Your X Account

Download The Market Wire News App